Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRO
3001
DELISTED
Agria Corp
GRO
| $273K | ﹤0.01% |
276,000
+5,400
| +2% | +$5.7K |
|
|
GV
3002
DELISTED
Goldfield Corporation
GV
| $272K | ﹤0.01% |
160,000
+10,200
| +7% | +$14K |
|
3003
DLH Holdings
DLHC
$67.8M
| $269K | ﹤0.01% |
70,075
+4,700
| +7% | +$15.9K |
|
3004
Green Brick Partners
GRBK
$3.02B
| $269K | ﹤0.01% |
+35,435
| New | +$219K |
|
3005
NLI Holdings
NL
$329M
| $268K | ﹤0.01% |
118,399
+38,599
| +48% | +$91.5K |
|
|
VOXX
3006
DELISTED
VOXX International Corporation Class A
VOXX
| $268K | ﹤0.01% |
59,900
+45,200
| +307% | +$198K |
|
|
HCCI
3007
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $267K | ﹤0.01% |
26,900
+14,400
| +115% | +$126K |
|
|
CORV
3008
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $267K | ﹤0.01% |
65,313
+3,100
| +5% | +$16.6K |
|
3009
AMREP Corp
AXR
$118M
| $265K | ﹤0.01% |
60,280
+4,000
| +7% | +$16.1K |
|
3010
Mind CTI
MNDO
$20.6M
| $265K | ﹤0.01% |
131,200
-7,175
| -5% | -$16.5K |
|
|
TISA
3011
DELISTED
TOP Image Systems Ltd
TISA
| $264K | ﹤0.01% |
172,300
+43,600
| +34% | +$95.2K |
|
3012
First Bancorp
FBP
$4.46B
| $263K | ﹤0.01% |
+90,100
| New | +$240K |
|
3013
Ooma
OOMA
$553M
| $261K | ﹤0.01% |
+44,300
| New | +$283K |
|
|
SOFO
3014
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
| $261K | ﹤0.01% |
40,119
+1,700
| +4% | +$9.5K |
|
3015
Insight Enterprises
NSIT
$4.54B
| $258K | ﹤0.01% |
9,000
-11,500
| -56% | -$290K |
|
3016
Akebia Therapeutics
AKBA
$248M
| $257K | ﹤0.01% |
28,500
-80,700
| -74% | -$654K |
|
3017
Phio Pharmaceuticals
PHIO
$12.7M
| $257K | ﹤0.01% |
2
+1
| +100% | +$176K |
|
|
EGT
3018
DELISTED
Entertainment Gaming Asia Inc.
EGT
| $256K | ﹤0.01% |
128,191
+3,200
| +3% | +$6.13K |
|
3019
Perma-Fix Environmental Services
PESI
$412M
| $255K | ﹤0.01% |
68,844
+13,644
| +25% | +$51.2K |
|
3020
Huron Consulting
HURN
$2.39B
| $254K | ﹤0.01% |
+4,358
| New | +$241K |
|
3021
Protolabs
PRLB
$2.17B
| $254K | ﹤0.01% |
3,300
-2,600
| -44% | -$168K |
|
|
FFWM
3022
DELISTED
First Foundation Inc
FFWM
| $253K | ﹤0.01% |
22,600
-90,600
| -80% | -$997K |
|
|
EDN
3023
Edenor
EDN
$994M
| $252K | ﹤0.01% |
15,100
-31,800
| -68% | -$522K |
|
3024
Gorman-Rupp
GRC
$2.15B
| $252K | ﹤0.01% |
+9,700
| New | +$242K |
|
|
GSV
3025
DELISTED
Gold Standard Ventures Corp.
GSV
| $252K | ﹤0.01% |
+242,700
| New | +$198K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.